abstract |
The present invention relates to the use of the compound as an inhibitor of 2-aza-bicyclo [2.2.1] heptane-3-carboxylic acid (cyano-methyl) -amide of formula (1) and cathepsin C, the compound The present invention relates to pharmaceutical compositions containing and methods of using the compounds as agents for the treatment and / or prevention of diseases associated with dipeptidyl peptidase I activity, such as respiratory diseases. (1) |